Cereno Scientifi announced that the representatives of the nomination committee have been appointed ahead of the annual general meeting 2024. The nomination committee has been appointed in accordance with the principles for the nomination committee which were established by the annual general meeting on June 1, 2023. According to the principles for the nomination committee that were resolved at the annual general meeting on April 16, 2024, the nomination committee should be appointed as follows.

The Company?s largest shareholder, or group of shareholders, as of 30 April 2024, shall have the right to appoint one member of the Nomination Committee. Furthermore, the Nomination Committee shall consist of the chairman of the Board of Directors, who shall also be the convener. In addition, Björn Dahlöf, CSO and Head of Clinical Development in the Company, shall be a member of the Nomination Committee.

The Nomination Committee shall thus consist of three persons. The nomination committee ahead of the annual general meeting 2025 has thus been appointed and comprises: Cihan Punar, representing the company?s largest group of shareholders per April 30, 2024, Joakim Söderström, convening member and Chair of the Board of Cereno, and Björn Dahlöf, CSO and Head of Clinical Development in the Company. One of the members, but not the chairman of the Board of Directors, shall be appointed as chairman of the Nomination Committee.

The Nomination Committee?s term of office extends until a new Nomination Committee is appointed.